data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
ENDRA Life Sciences
(NASDAQ:NDRA)
$0.2332
-0.0015[-0.64%]
At close: Jun 30
$0.2251
-0.0081[-3.47%]
After Hours: 4:09PM EDT
Day High/Low0.22 - 0.24
52 Week High/Low0.18 - 2.35
Open / Close0.23 / 0.23
Float / Outstanding62.3M / 63.2M
Vol / Avg.623.4K / 3M
Mkt Cap14.7M
P/E-
50d Avg. Price0.24
Div / Yield-
Payout Ratio-
EPS-0.08
Total Float62.3M

ENDRA Life Sciences (NASDAQ:NDRA), Quotes and News Summary

ENDRA Life Sciences (NASDAQ: NDRA)

Day High/Low0.22 - 0.24
52 Week High/Low0.18 - 2.35
Open / Close0.23 / 0.23
Float / Outstanding62.3M / 63.2M
Vol / Avg.623.4K / 3M
Mkt Cap14.7M
P/E-
50d Avg. Price0.24
Div / Yield-
Payout Ratio-
EPS-0.08
Total Float62.3M
Benzinga - 1 day ago
Benzinga - 2 days ago
Benzinga - May 17, 2022, 4:19PM
Benzinga - May 12, 2022, 5:31PM
Benzinga - May 10, 2022, 8:10AM
Benzinga - Apr 21, 2022, 8:08AM
Benzinga - Apr 7, 2022, 6:24AM
Benzinga - Mar 30, 2022, 4:17PM
Benzinga - Mar 30, 2022, 9:12AM
Benzinga - Mar 8, 2022, 8:11AM
Benzinga - Feb 11, 2022, 8:05AM
load more
Sector: Health Care.Industry: Health Care Equipment & Supplies
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.070-0.070 0.0000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

ENDRA Life Sciences Questions & Answers

Q
How do I buy ENDRA Life Sciences (NDRA) stock?
A

You can purchase shares of ENDRA Life Sciences (NASDAQ: NDRA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are ENDRA Life Sciences's (NDRA) competitors?
Q
What is the target price for ENDRA Life Sciences (NDRA) stock?
A

The latest price target for ENDRA Life Sciences (NASDAQ: NDRA) was reported by HC Wainwright & Co. on Thursday, April 7, 2022. The analyst firm set a price target for 5.00 expecting NDRA to rise to within 12 months (a possible 2044.08% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for ENDRA Life Sciences (NDRA)?
A

The stock price for ENDRA Life Sciences (NASDAQ: NDRA) is $0.2332 last updated June 30, 2022, 8:00 PM UTC.

Q
Does ENDRA Life Sciences (NDRA) pay a dividend?
A

There are no upcoming dividends for ENDRA Life Sciences.

Q
When is ENDRA Life Sciences (NASDAQ:NDRA) reporting earnings?
A

ENDRA Life Sciences’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is ENDRA Life Sciences (NDRA) going to split?
A

There is no upcoming split for ENDRA Life Sciences.

Q
What sector and industry does ENDRA Life Sciences (NDRA) operate in?
A

ENDRA Life Sciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.